Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

Overview of attention for article published in PharmacoEconomics, May 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 public wall post.

#HealthEconJA Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.